ADIAL PHARMACEUTICALS Files 8-K on Equity Incentive Plan
Ticker: ADIL · Form: 8-K · Filed: Apr 9, 2026 · CIK: 0001513525
| Field | Detail |
|---|---|
| Company | Adial Pharmaceuticals, Inc. (ADIL) |
| Form Type | 8-K |
| Filed Date | Apr 9, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, equity-incentive-plan, filing
TL;DR
ADIAL PHARMACEUTICALS updated its equity incentive plan, filing an 8-K on 4/9/2026.
AI Summary
ADIAL PHARMACEUTICALS, INC. filed an 8-K on April 9, 2026, reporting changes in officers and compensatory arrangements. Specifically, the company entered into a Form of Restricted Stock Award Agreement under its 2017 Equity Incentive Plan.
Why It Matters
This filing indicates potential changes in executive compensation and equity grants, which could impact shareholder value and employee incentives.
Risk Assessment
Risk Level: low — The filing is a routine disclosure regarding executive compensation and equity plans, not indicating immediate financial distress or significant operational changes.
Key Players & Entities
- ADIAL PHARMACEUTICALS, INC. (company) — Filer of the 8-K
- 2017 Equity Incentive Plan (plan) — Subject of the Restricted Stock Award Agreement
FAQ
What specific compensatory arrangements were made under the 2017 Equity Incentive Plan?
The filing indicates a 'FORM OF RESTRICTED STOCK AWARD AGREEMENT UNDER 2017 EQUITY INCENTIVE PLAN' was filed as an exhibit, suggesting new or updated stock awards.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 9, 2026.
What is the CIK number for ADIAL PHARMACEUTICALS, INC.?
The CIK number for ADIAL PHARMACEUTICALS, INC. is 0001513525.
What are the business and mailing addresses for ADIAL PHARMACEUTICALS, INC.?
Both the business and mailing addresses are listed as 1180 SEMINOLE TRAIL SUITE 495 CHARLOTTESVILLE VA 22901.
Which items of Form 8-K are addressed in this filing?
This filing addresses Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers) and Item 9.01 (Financial Statements and Exhibits).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 9, 2026 regarding ADIAL PHARMACEUTICALS, INC. (ADIL).